Cover Image
市場調查報告書

人體生長荷爾蒙 (HGH)的全球市場:產業分析與未來展望

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 336016
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
人體生長荷爾蒙 (HGH)的全球市場:產業分析與未來展望 Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年01月18日 內容資訊: 英文 78 Pages
簡介

本報告提供全球人體生長荷爾蒙 (HGH) 市場相關調查分析,疾病、產品概要和市場動態,整體市場規模的變化及預測,各市場區隔、各國詳細趨勢,競爭情形,主要企業簡介的資訊彙整,為您概述為以下內容。

第1章 概要

  • 人體生長荷爾蒙 (hGH)
  • hGH的生理作用
  • 生長激素缺乏症 (GHD)
  • 基因改造型人體生長荷爾蒙 (rhGH)
  • hGH市場:各症狀

第2章 全球人體生長荷爾蒙市場

  • hGH市場成果值 (以金額為準)
  • hGH市場預測價值 (以金額為準)
  • hGH市場成果值 (以數量為準)
  • hGH市場預測價值 (以數量為準)
  • 各症狀的市場趨勢
    • 兒童性hDH市場:成果值、預測值 (以金額為準)
    • 其他hGH市場:成果值、預測值 (以金額為準)
  • 全球hGH市場:各地區

第3章 市場規模

  • 美國
    • hGH市場成果值 (以金額為準)
    • hGH市場預測價值 (以金額為準)
    • hGH市場:各症狀
    • 兒童性GHD市場預測價值 (以金額為準)
  • 歐洲
  • 日本

第4章 市場動態

  • 成長推動因素
  • 市場趨勢、動靜
  • 課題

第5章 競爭情形

  • 全球hGH市場
    • 各企業的市場佔有率
    • 純銷售額、市值比較
  • 美國的hGH市場:各企業市場佔有率

第6章 企業簡介

  • Novartis AG
    • 產業概要
    • 主要的財務指標
    • 產業策略
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novo Nordisk A/S

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Growth hormone (GH)/ Human Growth hormone (hGH) is a type of peptide hormone produced by the body which is responsible for stimulating cell reproduction, growth and regeneration amongst humans. Within the anterior of pituitary glands, lateral wings are present the somatotropic cells which synthesize, store, and secrete the GH, a 191-amino acid in single chain polypeptide. It is responsible for keeping a check over the normal human growth and development especially amongst the teenagers and children. Apart from stimulating cell growth and maintaining muscle mass, hGH also prompts the liver to produce IGF-l which in turn regulates the metabolic functioning of muscles, tissues and osteocytes.

The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD), which is a medical condition affecting both children and adults. Amongst children, GHD could be associated with congenital conditions, like marred pituitary development and other genetic abnormalities. On the other hand, GHD amongst adults is supposedly linked with pituitary tumors and it usually has non-specific symptoms, like weight gain, reduced energy levels, disturbed sleep, and emotional sickness. Depending upon the indications targeted, the hGH market can be segmented into two broad categories; Pediatric GHD and others. Others segment include adult GHD, PWS, ISS and other GH related abnormalities.

The global hGH market is driven by development and entry of long-acting drugs, rising cases of cancer and HIV/AIDS, higher incidence of GHD and other related diseases, rising healthcare expenditure and increasing purchasing power. However, this market growth is challenged by high cost of drugs, off-label uses of hGH drugs and side effects related to rhGH.

The report "Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on the US, Europe and Japan. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Novartis AG., Pfizer Inc., Eli Lilly and Company and Novo Nordisk A/S are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global human growth market along with the study of the regional markets.

Table of Contents

1. Overview

  • 1.1 Human Growth Hormone
  • 1.2 Physiological Effects of hGH
  • 1.3 GH Deficiency (GHD)
  • 1.4 Recombinant Human Growth Hormone (rhGH)
  • 1.5 hGH Market by Indications

2. Global hGH Market

  • 2.1 Global hGH Market by Value
  • 2.2 Global hGH Market Forecast by Value
  • 2.3 Global hGH Market by Volume
  • 2.4 Global hGH Market Forecast by Volume
  • 2.5 Global hGH Market by Indications
    • 2.5.1 Global Pediatric GHD Market by Value
    • 2.5.2 Global Pediatric GHD Market Forecast by Value
    • 2.5.3 Global Other hGH Market by Value
    • 2.5.4 Global Other hGH Market Forecast by Value
  • 2.6 Global hGH Market by Regions

3. Regional Markets

  • 3.1 The US
    • 3.1.1 The US hGH Market by Value
    • 3.1.2 The US hGH Market Forecast by Value
    • 3.1.3 The US hGH Market by Indication
    • 3.1.4 The US Pediatric GHD Market Forecast by Value
  • 3.2 Europe
    • 3.2.1 Europe hGH Market by Value
    • 3.2.2 Europe hGH Market Forecast by Value
    • 3.2.3 Europe hGH Market by Indication
    • 3.2.4 Europe Pediatric GHD Market Forecast by Value
  • 3.3 Japan
    • 3.3.1 Japan hGH Market by Value
    • 3.3.2 Japan hGH Market Forecast by Value
    • 3.3.3 Japan hGH Market by Indication
    • 3.3.4 Japan Pediatric GHD Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Development and Entry of Long-Acting Drugs
    • 4.1.2 Rising Cases of Cancer and HIV/AIDS
    • 4.1.3 Increasing Incidence of CKD and ESRD
    • 4.1.4 Upsurge in Healthcare Expenditure
    • 4.1.5 Increasing Global GDP
    • 4.1.6 Higher Incidence of GHD and Other Related Diseases
  • 4.2 Trends & Development
    • 4.2.1 hGh Used as Performance Enhance Drug
    • 4.2.2 Innovation in Drug Delivery System
  • 4.3 Challenges
    • 4.3.1 High Cost of Treatment
    • 4.3.2 Off Label Uses of GH
    • 4.3.3 Side Effects of rhGH

5. Competitive Landscape

  • 5.1 Global hGH Market
    • 5.1.1 Global hGH Market Share by Company
    • 5.1.2 Net Sales and Market Cap Comparison
  • 5.2 The US hGH Market Share

6. Company Profiles

  • 6.1 Novartis AG
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Pfizer Inc.
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Eli Lilly and Company
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Novo Nordisk A/S
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • hGH Secretion Control
  • hGH's Physiological Effect
  • hGH Market Segmentation by Indication
  • Global hGH Market by Value (2012-2016)
  • Global hGH Market Forecast by Value (2017-2021)
  • Global hGH Market by Volume (2012-2016)
  • Global hGH Market Forecast by Volume (2017-2021)
  • Global hGH Market by Indications (2016)
  • Global Pediatric GHD Market by Value (2012-2016)
  • Global Pediatric GHD Market Forecast by Value (2017-2021)
  • Global Other hGH Market by Value (2012-2016)
  • Global Other hGH Market Forecast by Value (2017-2021)
  • Global hGH Market by Regions (2016)
  • The US hGH Market by Value (2012-2016)
  • The US hGH Market Forecast by Value (2017-2021)
  • The US hGH Market by Indication (2016)
  • The US Pediatric GHD Market Forecast by Value (2016-2021)
  • Europe hGH Market by Value (2012-2016)
  • Europe hGH Market Forecast by Value (2017-2021)
  • Europe hGH Market by Indication (2016)
  • Europe Pediatric GHD Market Forecast by Value (2016-2021)
  • Japan hGH Market by Value (2012-2016)
  • Japan hGH Market Forecast by Value (2017-2021)
  • Japan hGH Market by Indication (2016)
  • Japan Pediatric GHD Market Forecast by Value (2016-2021)
  • Global New Cancer Patients by Volume (2012-2016)
  • Global ESRD Patients Volume (2012-2016)
  • Global Healthcare Expenditure Per Capita (2012-2016)
  • Global GDP Per Capita (2012-2016)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global hGH Market Share by Company (2016)
  • The US hGH Market Value Share by Company (2016)
  • Novartis AG Revenue by Segment (2015)
  • Novartis AG Revenue and Net Income (2011-2015)
  • Novartis AG R&D Expenditure (2013-2015)
  • Pfizer Inc. Revenue by Segment (2015)
  • Pfizer Inc. Revenue and Net Income (2011-2015)
  • Pfizer Inc. R&D Expenditure (2013-2015)
  • Eli Lilly and Company Revenue by Segment (2015)
  • Eli Lilly and Company Revenue and Net Income (2011-2015)
  • Eli Lilly and Company R&D Expenditure (2013-2015)
  • Novo Nordisk A/S Revenue by Segment (2015)
  • Novo Nordisk A/S Net Sales and Net Profit (2011-2015)
  • Novo Nordisk A/S R&D Expenditure (2013-2015)

List of Tables

  • Long acting hGH Drugs in Pipeline (2016)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global hGH Sales & Capitalization by Company (2015)
  • New Products of Pfizer with FDA Approval (2015/2016)
  • New Products of Novo Nordisk A/S in Pipeline (2016)
Back to Top